手机验证
Fibronectin (Red fluorescent, rhodamine)
FNR01-A
cytoskeleton
上海研卉生物
Fibronectin红色标记
5X20UG
Product | Cat. # | |
Fibronectin (Red fluorescent, rhodamine) |
FNR01 | |
Fibronectin |
FNR02 | |
Fibronectin (Biotinylated) |
FNR03 | |
Laminin (Red fluorescent, rhodamine) |
LMN01 | |
Laminin (Green fluorescent, HiLyte488TM) |
LMN02 | |
Laminin (Biotinylated) |
LMN03 |
Role in disease
Aberrant regulation or genetic defects of the ECM components often results in a pathogenic state.
Genetic diseases: Several diseases have been shown to be caused by mutations in ECM genes, including macular degenerative disease (Fibulin 3, ref. 6), osteoarthritis (Asporin, ref. 7) and congenital muscular dystrophy (Laminins, ref. 8).
Cancer and Metastasis: There are many examples demonstrating that altered expression of a given ECM protein is correlated with cancer (9). It is also well established that degradation of the ECM, via the actions of matrix metalloproteinases, is a prerequisite to metastatic invasion of cancer cells (10).
Atherosclerosis: This disease has been linked to a buildup of collagen plaques (11).
Biomedical Applications
The field of regenerative medicine and tissue engineering is utilizing ECM components to try to generate a predictable formation of tissues and organs from a given cell type (12,13).
Assays Used to study ECM
There is a preponderance of commercially available ECM reagents and cell attachment/invasion assays. The best known of the ECM reagents is MatrigelTM from BD which is an ECM extract from the Engelbreth-Holm-Swarm mouse tumor. MatrigelTM is composed of laminin (56%), collagen type IV (31%), and enactin (8%), and several growth factors, including EGF (0.7 ng/ml), PDGF (12 ng/ml), IGF-1 (16ng/ml), and TGF-a (2.3 ng/ml) (14). Similar products include ECMatrixTM (Millipore) and ECM gel (Sigma). Most commercially available invasion assays utilize a Boyden-chamber like system (15).
Cytoskeleton offers a unique line of fluorescently-labeled and biotinylated fibronectins and laminins. Several applications of these products are listed below.
Application #1: In vitro invadopodia/podosome invasion assay (Cat.# FNR01, FNR02, LMN01, LMN02)
Cytoskeleton’s fluorescently-labeled fibronectins and laminins can be used in an in vitro invadopodia/podosome invasion assay (16). This assay allows a high resolution examination of local cell invasion on specific ECM components and can be used to assess the invasive potential of cells and to examine compounds/pathways that affect this stage of invasion. Originally described by Artym et al. for gelatin, the assay is equally applicable to fluorescent fibronectin or laminin (16).
Application #2: Signaling Pathways Involved in Fibronectin Matrix Assembly: Fibrillogenesis (Cat.# FNR01, FNR02, FNR03)
Unlike other ECM components that can self-polymerize under physiological conditions, fibronectin matrix assembly is a cell-dependent process. Understanding the mechanisms involved in FN assembly and how these interplay with cellular, fibrotic, and immune responses may reveal targets for the future development of therapies to regulate aberrant tissue-repair processes. Also, tissue engineering strongly depends on the ability to control the rate and pattern of ECM formation. Cytoskeleton’s labeled fibronectins can be used to monitor fibrillogenesis;
Fluorescent Fibronectin Substrates (FNR01 & FNR02)
This method involves fluorescent tracing of fibril formation through incorporation of fluorescent fibronectins (17).
The conversion of soluble fibronectin to insoluble fibrils on the cell surface can be visualized by feeding cell culture with media containing either TRITC-labeled fibronectin (Cat.# FNR01) or HiLyte488-labeled fibronectin (Cat.# FNR02). The level of incorporated fibronectin can be observed and quantitated by fluorescence microscopy (18).
Biotinylated Fibronectin Substrate (FNR03)
This method incorporates biotinylated fibronectin into the cells of interest and quantitates detergent soluble (cell bound) and detergent insoluble (fibrils) fibronectin. This assay has been used successfully to examine the role of Rho proteins in fibrillogenesis (19).
Application #3: Tissue Engineering Applications (FNR03 & LMN03)
It has been shown that biotinylated ECM proteins can adopt a more native conformation when bound to a streptavidin surface and that this can lead to enhanced cellular binding to the ECM (20).
References
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。